To further support your goals, we provide optional nutrition and wellness consultations
"New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases"
The consistency of the data across thousands of participants is what makes semaglutide uniquely well-supported among peptides for weight loss
Effectiveness of quercetin in an experimental rat model of allergic rhinitis
Ongoing Support Follow-up care gives patients an opportunity to discuss questions, progress, side effects and treatment concerns
Farxiga/Forxiga is not currently approved for weight loss as a standalone indication in non-diabetics, but the evidence is accumulating: Currently, if weight loss is the primary goal in a non-diabetic patient, GLP-1 agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) produce substantially greater weight loss (1015% vs 24%)